This starts your 28-day clock
useful for upper GI targeting Troches buccal absorption, limited evidence specific to BPC-157 Who oral delivery is best suited for: Leaky gut / intestinal permeability Inflammatory bowel disease (IBD, Crohn's, ulcerative colitis) NSAID-induced gastric damage or ulcers Irritable bowel syndrome (IBS) General GI maintenance alongside other therapies Patients who cannot or will not self-inject Practical considerations: Oral bioavailability is lower for systemic goals do not expect injection-equivalent tendon or joint results Dosing protocols typically require three to ten times the injectable dose to achieve comparable GI effects Product quality varies widely in the oral supplement market sourcing from a licensed compounding pharmacy is essential Nasal BPC-157: Emerging Option, Limited Evidence Nasal BPC-157 is the third delivery route and the least established

A broken seal or signs of leakage Check that the cap and stopper are intact, with no cracks, leaks, or liquid pooled around the top, since a broken seal can mean contamination
Some studies have incorporated a loading regimen with higher initial doses, followed by lower maintenance doses of 1-2mg per week
Can you get rid of crows feet
No completed, published, randomized controlled human trial exists for BPC-157 in any indication